Melanoma Overdiagnosis: Historical Perspective and the Path Forward

Melanoma Overdiagnosis: Historical Perspective and the Path Forward

Authors

  • Ashfaq A. Marghoob Memorial Sloan Kettering Skin Cancer Center, New York, USA

References

Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970 Nov;172(5):902-8.

Ackerman AB. No one should die of malignant melanoma. J Am Acad Dermatol. 1985 Jan;12(1 Pt 1):115-6.

Friedman RJ, Rigel DS, Silverman MK, Kopf AW, Vossaert KA. Malignant melanoma in the 1990s: the continued importance of early detection and the role of physician examination and self-examination of the skin. CA Cancer J Clin. 1991 Jul-Aug;41(4):201-26.

Grob JJ, Bonerandi JJ. The 'ugly duckling' sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. Arch Dermatol. 1998 Jan;134(1):103-4.

McGovern TW, Litaker MS. Clinical predictors of malignant pigmented lesions. A comparison of the Glasgow seven-point checklist and the American Cancer Society's ABCDs of pigmented lesions. J Dermatol Surg Oncol. 1992 Jan;18(1):22-6.

Slue W, Kopf AW, Rivers JK. Total-body photographs of dysplastic nevi. Arch Dermatol. 1988 Aug;124(8):1239-43.

Rosendahl C, Cameron A, Bulinska A, Williamson R, Kittler H. Dermatoscopy of a minute melanoma. Australas J Dermatol. 2011 Feb;52(1):76-8.

Argenziano G, Kittler H, Ferrara G, Rubegni P, Malvehy J, Puig S, Cowell L, Stanganelli I, De Giorgi V, Thomas L, Bahadoran P, Menzies SW, Piccolo D, Marghoob AA, Zalaudek I. Slow-growing melanoma: a dermoscopy follow-up study. Br J Dermatol. 2010 Feb 1;162(2):267-73.

Scolyer RA, Murali R, McCarthy SW, Thompson JF. Pathologic examination of sentinel lymph nodes from melanoma patients. Semin Diagn Pathol. 2008 May;25(2):100-11.

Menzies SW, Liyanarachchi S, Coates E, Smith A, Cooke-Yarborough C, Lo S, Armstrong B, Scolyer RA, Guitera P. Estimated risk of progression of lentigo maligna to lentigo maligna melanoma. Melanoma Res. 2020 Apr;30(2):193-197.

Welch HG, Mazer BL, Adamson AS. The Rapid Rise in Cutaneous Melanoma Diagnoses. N Engl J Med. 2021 Jan 7;384(1):72-79.

Olsen CM, Whiteman DC. Cutaneous Melanoma in White Americans: A Tale of Two Epidemics. J Invest Dermatol. 2022 Jul;142(7):1765-1767.

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/melanoma-in-situ

Glasziou PP, Jones MA, Pathirana T, Barratt AL, Bell KJ. Estimating the magnitude of cancer overdiagnosis in Australia. Med J Aust. 2020 Mar;212(4):163-168.

Kurtansky NR, Dusza SW, Halpern AC, Hartman RI, Geller AC, Marghoob AA, Rotemberg VM, Marchetti MA. An Epidemiologic Analysis of Melanoma Overdiagnosis in the United States, 1975-2017. J Invest Dermatol. 2022 Jul;142(7):1804-1811.e6.

Downloads

Published

2023-10-31

Issue

Section

Kramer vs Kramer

How to Cite

1.
Melanoma Overdiagnosis: Historical Perspective and the Path Forward. Dermatol Pract Concept [Internet]. 2023 Oct. 31 [cited 2024 Jul. 13];13(4):e2023249. Available from: https://dpcj.org/index.php/dpc/article/view/3750

Share